Dextromethorphan and guaifenesin use should be monitored thoroughly in patients with "poor metabolizer" CYP2D6 enzyme degrees and individuals that are sedated. This combination medication features a massive median toxic dose (TD50) to median efficient dose (ED50) ratio (or therapeutic index) in these people. Delsym has a full line of cough https://admiralbookmarks.com/story18212171/new-step-by-step-map-for-dextromethorphan-dxm-for-sale-in-europe